Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Akebia Therapeutics (NQ: AKBA )

2.860 USD -0.050 (-1.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,538,834
Open 2.880
Bid (Size) 2.910 (1)
Ask (Size) 2.930 (10)
Prev. Close 2.910
Today's Range 2.840 - 2.940
52wk Range 2.090 - 5.140
Shares Outstanding 174,537,458
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted nine newly-hired employees options to purchase... 
From PR Newswire
Akebia Therapeutics Announces September 2021 Investor Conference Schedule
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive... 
From PR Newswire

Performance

YTD
-2.05%
-2.05%
1 Month
+0.35%
+0.35%
3 Month
-29.90%
-29.90%
6 Month
-7.74%
-7.74%
1 Year
+17.21%
+17.21%

More News

Read More
Akebia Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Milestones
From PR Newswire
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From PR Newswire
Akebia Therapeutics to Report Second Quarter 2021 Financial Results and Discuss Recent Business Highlights
From PR Newswire
3 Hot Biotech Penny Stocks to Watch With High Volume in 2021
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
First Week of AKBA October 15th Options Trading
Tags Stocks
From Market News Video
Interesting AKBA Put And Call Options For January 2022
Tags Stocks
From Market News Video
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akebia Therapeutics, Inc. and Encourages Investors who Formerly Held Shares of Keryx Biopharmaceuticals (KERX) to
From Business Wire News Releases
These Penny Stocks Are Frequently Talked About on Reddit, Here’s Why
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
SHAREHOLDER ALERT: Robbins LLP Announces that Akebia Therapeutics, Inc. (AKBA) is Being Sued for Misleading Keryx Biopharmaceuticals, Inc. (KERX) Shareholders Ahead of Merger
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.